This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Medicaid & Government Pricing Congress
Delivered as a Hybrid Event May 23 - June 2, 2022
In-Person: May 23-25 ● Virtual: June 1-2Sheraton Philadelphia Downtown, Philadelphia, PA

Edward Burley
Deputy Regional Inspector General at Office of Inspector General, U.S. Department of Health and Human Services


In his 20 years with OEI, Ed has worked on over 20 evaluation reports that focused on prescription drug pricing, reimbursement, and rebate policies under Medicare and Medicaid. As a result of other evaluations conducted by Ed, Congress enacted legislative changes to the Medicaid drug rebate program that increased the amount of Medicaid rebates collected by States and CMS. Most recently, Ed’s work has been the impetus for CMS to lower reimbursement amounts for certain Part B-covered drugs. Ed has a bachelor’s and a master’s degree in political science from Villanova University.

Agenda Sessions

  • Mandated OIG Prescription Drug Studies